Q5136 Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg

Short descriptor: Inj. denosumab-bbdz, 1 mg

✓ Active HCPCS Level II 2026
Open Q5136 in the app →

Look up Q5136 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q5136 is the HCPCS Level II code for Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2024-10-01
2026 Maintenance
No change this year

References

Cite This Page

Reference Q5136 with the canonical source and edition:

Q5136 — Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q5136

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q5136

Related Codes in Section Q

← Q5135 Inj, tyenne, 1 mg Q5137 → Inj, wezlana, sub cu, 1 mg
Q5132 Inj, abrilada, 10 mg Q5133 Inj, tofidence, 1 mg Q5134 Inj, tyruko, 1 mg Q5135 Inj, tyenne, 1 mg Q5137 Inj, wezlana, sub cu, 1 mg Q5138 Inj, wezlana, iv, 1 mg Q5139 Inj, eculizumab-aeeb, 10 mg Q5140 Inj adalimumab-fkjp, 1 mg Q5141 Inj adalimumab-aaty, 1 mg Q5142 Inj adalimumab-ryvk, 1 mg
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial